In addition, CerK expression was found to be higher in estrogen receptor (ER)-negative than in ER-positive breast cancer, and within the ER-negative subgroup of patients, those with highest CerK expression had the worst prognosis and the shortest survival [21]. The gene discussed is ESR1; the disease is breast cancer.